Mesenchymal stem cell therapy in type 2 diabetes mellitus

Mesenchymal stem cell therapy in type 2 diabetes mellitus

Abstract Type 2 diabetes mellitus (T2DM), which is characterized by the combination of relative insulin deficiency and insulin resistance, cannot be reversed with existing therapeutic strategies. Transplantation of insulin-producing cells (IPCs) was once thought to be the most promising strategy for...

Full description

Bibliographic Details
Main Authors: Li Zang, Haojie Hao, Jiejie Liu, Yijun Li, Weidong Han, Yiming Mu
Format: Article
Language:English
Published: BMC 2017-05-01
Series:Diabetology & Metabolic Syndrome
Subjects:
Mesenchymal stem cells
Type 2 diabetes mellitus
Insulin resistance
Online Access:http://link.springer.com/article/10.1186/s13098-017-0233-1

Similar Items

Similar Items